Fig. 5

Comparison of log2 ratio levels between cisplatin responders and non-responders. Key genes are included (A) NCOA3, (B) DEPDC5, (C) TPK1, (D) CEP57L1, (E) PLXNA4.

Comparison of log2 ratio levels between cisplatin responders and non-responders. Key genes are included (A) NCOA3, (B) DEPDC5, (C) TPK1, (D) CEP57L1, (E) PLXNA4.